Supplementary Appendix - Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Supplemental figures and tables
应用场景：
创建时间：
2020-08-24
相关数据集
Analysis of interleukin 23 and 7G10 interactions for computational design of lead antibodies against immune-mediated inflammatory diseases
Wealth of structural data on theurapeutic targets in complex with monoclonal antibodies (mAbs) and advances in molecular modeling algorithms present exciting opportunities in the field of novel biolog
NIAID Data Ecosystem40
Low morbidity in Danish patients with common variable immunodeficiency disorder infected with severe acute respiratory syndrome coronavirus 2
Manifestations and outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are not well documented in patients with common variable immunodeficiency disorder (CVID). A Danis
Taylor & Francis Group2021-10-25 更新20
datasheet1_COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments.docx
The effect of immunosuppressant treatments on the incidence of coronavirus disease (COVID-19) remains largely unknown. We studied the association between the pre-exposure to disease-modifying antirheu
NIAID Data Ecosystem10
DataSheet1_Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection.PDF
Aging population is at higher risk of developing severe COVID-19, including hospitalization and death. In this work, to further understand the relationship between host age-related factors, immunosene
NIAID Data Ecosystem20
Causal relationships between interleukins, interferons and COVID-19 risk: a Mendelian randomization study
Observational studies have shown close associations between COVID-19 risk and cytokines, especially interleukins (ILs) and interferons (IFNs). However, the causal relationships between ILs, IFNs and C
NIAID Data Ecosystem10
